财务
- Market Capitalization 1.78 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.02
市销率
0.98
相关股票代码
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2009 | MESO Mesoblast Limited - American Depositary Shares | 13.79 USD | -0.79% | +1.25% | -6.25% | -24.48% | 1.79 B USD | ||
| 2013 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 9.77 USD | -4.22% | -3.27% | +28.89% | +5.28% | 1.78 B USD | ||
| 2021 | VIR Vir Biotechnology, Inc. - Common Stock | 10.41 USD | -1.89% | -9.56% | -1.23% | +74.08% | 1.76 B USD | ||
| 2022 | ZYME Zymeworks Inc. - Common Stock | 24.77 USD | -1.20% | -5.60% | -5.35% | +39.63% | 1.76 B USD |